ECM
AVNS

Everence Capital Management’s Avanos Medical AVNS Stock Holding History

Everence Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,170
Closed -$200K – 743
2023
Q2 		$200K Hold
8,170
– – 0.02% 652
2023
Q1 		$243 Buy
+8,170
New +$237K 0.02% 616
2022
Q2 		– Sell
-13,540
Closed -$454K – 715
2022
Q1 		$454K Hold
13,540
– – 0.03% 435
2021
Q4 		$469K Hold
13,540
– – 0.03% 451
2021
Q3 		$422K Buy
+13,540
New +$459K 0.03% 451

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Everence Capital Management's AVNS Position: Q3 2023 in Review

Everence Capital Management sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 8,170 shares — an estimated $200K sold.

Everence Capital Management first reported a position in AVNS in Q3 2021 and held it in 5 quarters. The position peaked at $469K in Q4 2021. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.

  • Everence Capital Management reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
  • Everence Capital Management sold 8,170 Avanos Medical shares in Q3 2023, an estimated $200K.
  • Everence Capital Management first reported a position in Avanos Medical in Q3 2021 and held it in 5 quarters.
  • Everence Capital Management's Avanos Medical position peaked at $469K in Q4 2021.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.

Based on Everence Capital Management's 13F filing for Q3 2023, filed 16 Oct 2023.